Analysts: Buy These Healthcare Stocks

Only one stock is being able to capitalize on the bullish brokerage attention

Jul 24, 2018 at 2:29 PM
facebook X logo linkedin


Canaccord Genuity initiated coverage on Neuronetics Inc (NASDAQ:STIM) with a "buy" rating, and a $33 price target -- a 27% premium to last night's close, and uncharted territory for the Wall Street newcomer. The brokerage firm said the psychiatric specialist is a "compelling growth story," and cited a "first-mover advantage" for the company's NeuroStar platform, which uses Transcranial Magnetic Stimulation (TMS) to treat depression.

STIM shares initially jumped 3.8% in reaction to the bull note, but has since swung 0.1% lower to trade at $26.00. The stock opened for trading on June 28 at $25, well above the initial public offering (IPO) price of $17. Neuronetics stock rallied all the way up to $29.84 that day -- its highest point to date -- while its current all-time low of $23.96 was hit that same day.

Nevertheless, Canaccord Genuity isn't the first brokerage firm to wax optimistic on the healthcare stock. On Monday, July 23, William Blair began coverage on STIM stock with an "outperform" rating.

Roth Capital began coverage on Menlo Therapeutics Inc (NASDAQ:MNLO) with a "buy" recommendation and $29 price target, representing expected upside of 287% to Monday's close. The analyst in coverage cited the biopharmaceutical firm's mid- and late-stage trials for its pruritus treatments as potentially positive catalysts.

MNLO stock was up 12.7% at its intraday peak, and was last seen 3.1% higher at $7.73. The equity's longer-term technical performance has been far from inspiring, though, with the shares gapping nearly 77% lower back on April 9 following disappointing data for its itch treatment. Since then, the equity has been churning near its post-gap closing level, with today's rally running out of steam near the 50-day moving average.

mnlo stock daily chart july 24

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI